Microencapsulation of fish liver oil by complex coacervation method with gelatin-arabic gum

Similar documents
Optimization of morphology and geometry of encapsulated Hypophthalmichthys molitrix oil

IDENTIFICATION AND DETERMINATION OF HYDROQUINONE IN COSMETIC PRODUCTS 2 14/11/17 ACM 003 BY TLC AND HPLC

H 3 CO H 3 CO S CH 3

This method describes the identification of the following prohibited colorants in cosmetic products:

2017 Reaction of cinnamic acid chloride with ammonia to cinnamic acid amide

DEVELOPMENT AND VALIDATION OF NEW RP-HPLC METHOD FOR THE DETERMINATION OF AFLOQUALONE IN HUMAN PLASMA AND FORMULATION

8. FORMULATION OF LANSOPRAZOLE NANOPARTICLES

Fabrication of SiO 2, Al 2 O 3, and TiO 2 Microcapsules with Hollow Core and Mesoporous Shell Structure

Evolution of Solid Phase Homochirality for a. Proteinogenic Amino Acid

GB Translated English of Chinese Standard: GB NATIONAL STANDARD OF THE

NEVIRAPINE ORAL SUSPENSION Final text for addition to The International Pharmacopoeia (February 2009)

LUMEFANTRINUM LUMEFANTRINE

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE

Encapsulation of enzyme in metal ion-surfactant nanocomposites for

4023 Synthesis of cyclopentanone-2-carboxylic acid ethyl ester from adipic acid diethyl ester

MEDROXYPROGESTERONE INJECTION

Determination of Caffeine by HPLC

Carbon nanotube coated snowman-like particles and their electro-responsive characteristics. Ke Zhang, Ying Dan Liu and Hyoung Jin Choi

Appendix II- Bioanalytical Method Development and Validation

--> Buy True-PDF --> Auto-delivered in 0~10 minutes. GB Translated English of Chinese Standard: GB5009.

CYCLOSERINE Final text for addition to The International Pharmacopoeia. (November 2008) CYCLOSERINUM CYCLOSERINE

Very low temperature CO oxidation over colloidally deposited gold nanoparticles on Mg(OH) 2 and MgO

ARTEMETHER AND LUMEFANTRINE ORAL SUSPENSION:Final text for addition to The International Pharmacopoeia (November 2008)

SUPPLEMENTARY INFORMATION

IDENTIFICATION OF STEROIDS IN COSMETIC PRODUCTS BY TLC AND HPLC 1 02/12/2005 ACM 007 A. THIN LAYER CHROMATOGRAPHY (TLC)

DEVELOPMENT AND VALIDATION OF A HPLC METHOD FOR IN-VIVO STUDY OF DICLOFENAC POTASSIUM

2 Preparation of hollow spheres, microcapsules and microballoons by surfactant free emulsion templating

SUPPORTING INFORMATION

Molecular Weight Distribution of Living Chains in Polystyrene Pre-pared by Atom Transfer Radical Polymerization

Supplementary Information

The analysis of organic acid content of additives, premix, feed, and water.

Agilent 1200 Infinity Series HDR DAD Impurity Analyzer System for the Quantification of Trace Level of Genotoxic Impurity

CHAPTER 19 PARACETAMOL + IBUPROFEN

ARTEMETHER AND LUMEFANTRINE TABLETS: Final text for addition to The International Pharmacopoeia (July 2008)

5072 CHEMISTRY (NEW PAPERS WITH SPA) TOPIC 1: EXPERIMENTAL CHEMISTRY 5067 CHEMISTRY (NEW PAPERS WITH PRACTICAL EXAM) TOPIC 1: EXPERIMENTAL CHEMISTRY

Solution-processable graphene nanomeshes with controlled

Sacrifical Template-Free Strategy

Supporting Information

Supplementary Material (ESI) for Chemical Communications This journal is (c) The Royal Society of Chemistry 2009

The Nitrofurantoin Capsules Revision Bulletin supersedes the currently official monograph.

Supporting Information

A novel approach to the analysis of multivitamin by online supercritical fluid extraction/supercritical fluid chromatography

Supporting Information

EFAVIRENZ Final text for addition to The International Pharmacopoeia

429 LIGHT DIFFRACTION MEASUREMENT OF PARTICLE SIZE

Supporting Information

Supporting Information

High Pressure/Performance Liquid Chromatography (HPLC)

Effect of emulsion preparation method on microencapsulation of n-octadecane using melamine-formaldehyde pre-polymers

Plop Plop, Fizz Fizz, Oh What A Relief It Is (Which Pain Reliever Works Fastest)

ANALYTICAL METHOD PROCEDURES

School of Chemistry UNIVERSITY OF KWAZULU-NATAL, WESTVILLE CAMPUS JUNE 2009 EXAMINATION CHEM340: INSTRUMENTAL ANALYSIS.

BRIEFING. (EXC: K. Moore.) RTS C Propylparaben C 10 H 12 O Benzoic acid, 4 hydroxy, propyl ester; Propyl p hydroxybenzoate [ ].

Report AFK0242/18 TABLE OF CONTENTS

Supporting Information. Golf ball-shaped PLGA microparticles with internal pores fabricated by simple O/W emulsion

Validated RP-HPLC Method for Estimation of Cefprozil in Tablet Dosage Form

Development and Validation of Stability Indicating RP-HPLC Method for the Determination of Anagrelide HCl in Pharmaceutical Formulation

Simultaneous HPLC Determination of Methocarbamol, Paracetamol and Diclofenac Sodium

Development and Validation of a HPLC Method for Chlorphenamine Maleate Related Substances in Multicomponents Syrups and Tablets

12 Nicarbazin Nicarbazin (4,4 -dinitro carbanilid (DNC) and 2-hydroxy-4,6-dimethyl pyrimidine (HDP))

Electronic Supplementary Information

Supporting Information

Exploiting the Interaction of Pyranine-3 with Poly(L-Lysine) to Mediate Nanoparticle Assembly: Fabrication of Dynamic ph-responsive Nanocontainers

Dicyclomine-loaded Eudragit -based Microsponge with Potential for Colonic Delivery: Preparation and Characterization

Determination of Carbonyl Compounds In Water by Dinitrophenylhydrazine Derivatization and HPLC/UV*

Micro-encapsulation using an oil-in-water-in-air "Dry Water Emulsion"

TECHNICAL TEMEPHOS. 1. Specification. Full specification WHO/SIT/19.R4 Revised 10 December Description

Maximizing Triple Quadrupole Mass Spectrometry Productivity with the Agilent StreamSelect LC/MS System

Facile Synthesis and Optical Properties of Colloidal Silica Microspheres Encapsulating Quantum Dots-Layer

PREPARATION AND CHARACTERISATION OF PERFLUORODECALIN IN WATER PICKERING EMULSION

Dissolution study and method validation of alprazolam by high performance liquid chromatography method in pharmaceutical dosage form

Monodisperse magnetite nanoparticles with nearly ideal saturation magnetization

Growth of silver nanocrystals on graphene by simultaneous reduction of graphene oxide and silver ions with a rapid and efficient one-step approach

A RP-HPLC METHOD DEVELOPMENT AND VALIDATION OF PARA- PHENYLENEDIAMINE IN PURE FORM AND IN MARKETED PRODUCTS

Analytical Method Development and Validation of Lafutidine in Tablet dosage form by RP-HPLC

GB Translated English of Chinese Standard: GB NATIONAL STANDARD OF

Should you have any questions, please contact Mary P. Koleck, Ph.D., Scientific Liaison ( or

Journal of Drug Delivery and Therapeutics

Supporting Information. for. Advanced Materials, adma Wiley-VCH 2006

GUACO FOR HOMOEOPATHIC PREPARATIONS GUACO FOR HOMOEOPATHIC PREPARATIONS

637. Thiamethoxam. HPLC method

Impact factor: 3.958/ICV: 4.10 ISSN:

Supplementary Figure 1. Temperature profile of self-seeding method for polymer single crystal preparation in dilute solution.

Preparation of Cefuroxime Loaded PVP Particles by Supercritical Anti-Solvent Process

SUPPORTING INFORMATION

One-pot synthesis of micron partly hollow anisotropic dumbbell shaped silica core-shell particles

Block copolymers containing organic semiconductor segments by RAFT polymerization

In a typical routine, the pristine CNT (purchased from Bill Nanotechnology, Inc.) were

Supporting information

TOSYLHYDRAZONE CLEAVAGE OF AN α,β-epoxy KETONE; OXIDATIVE KMnO 4 CLEAVAGE OF AN ALKYNE EXPERIMENT A

Pickering emulsion engineering: Fabrication of materials with multiple cavities

Supplementary Information

Selective Formation of Benzo[c]cinnoline by Photocatalytic Reduction of 2,2 Dinitrobiphenyl with TiO 2 and UV light irradiation

Estimation of Chlorpyriphos in its Formulation (Paraban 20% EC) by Reversed-Phase HPLC

Supporting Information

Discovery of Decamidine as a New and Potent PRMT1 Inhibitor

Novel fluorescent matrix embedded carbon quantum dots enrouting stable gold and silver hydrosols

CHAPTER V ANALYTICAL METHODS ESTIMATION OF DICLOFENAC. Diclofenac (gift sample from M/s Micro Labs Ltd., Pondicherry)

Plop Plop, Fizz Fizz, Oh What A Relief It Is (Which Pain Reliever Works Fastest)

The microparticle system has become an indispensable part of the controlled drug delivery fields for the past few decades since it can

Transcription:

Microencapsulation of fish liver oil by complex coacervation method with gelatin-arabic gum Abstract Hiep X. Nguyen 1, Chien N. Nguyen 1,* 1 Department of Pharmaceutial Industry, Hanoi University of Pharmacy, Hanoi, 10000, Vietnam * Chiennnguyen@hup.edu.vn Fish liver oil was microencapsulated by complex coacervation with a gelatin arabic gum polymeric wall system. The effect of core/wall ratio, emulsification stirring speed, coacervation ph value, concentration of formaldehyde solution, ratio of gelatin/ arabic gum, weight of PVA, and microencapsules stabilizing time on the microcapsulation yield, encapsulation efficiency, particle size and morphology of microcapsules were investigated. The suitable conditions were determined and rational formulation were established. Keywords: Fish liver oil, complex coacervation, HPLC, extraction Introduction Microcapsule and microsphere have numerous advantages over tablet namely more stable bioavailabity amongst individuals since retention time of microcapsule is less fickle in intestinal tract. Microencapsulation especially takes active ingredients to undergo the metamorphosis from liquid state to solid form to be ultimately capsulated or tabletted [3], and also conceals both ingredients stinky odour and foul taste. Be based on that and the pharmaceutical project entitled Microencapsulation of fish liver oil by complex coacervation method with gelatin-arabic gum was excecuted with fish liver oil as drug model in order to investigate the effects of condition and formulation parameters on microencapsulation of fish liver oil. Materials, equipments and methods Materials Vitamin A palmitate, gelatin, gum arabic, fish liver oil, polyvinyl alcol (PVA): reach pharmaceutical standards. Other chemicals: reach analytical standards. Standard Vitamin A palmitate (500 mg/vial, 996,100 IU/g) is kindly provided by National Institute of Drug Quality Control. Equipments IKA RW 20 overhead digital stirrer, CHRIST Freeze Dryer, Refrigerated Centrifuge sigma 3 18K sartorius AG, Hettich Zentrifugen Centrifuge Rotina 46, IKA vortex Genius 3, Optical microscope Carl Zeiss, axiostar plus, High Performance Liquid Chromatography system (HPLC) Shimadzu, Scanning Electron Microscope (SEM) Hitachi S4800- NIHE 10000kV. Methods Preparation of microcapsules Microcapsules were prepared by complex coacervation method with a gelatin arabic gum polymeric wall system, analogous to the technique of Alavi Talab H. [1]. The incipient formula came as follows: 30g 12.5% gelatin solution was mixed with 30g 12.5% gum arabic solution at room temperature, stirring speed of 500rpm in 5 minutes (the first stirring stage). Added 4.2g fish liver oil, 0.5g PVA, 0.04g BHT (Butylated hydroxytoluene), and 10 ml distilled water to the mixture of gelatin solution and gum arabic solution, then continued agitating in 15 minutes, at room temperature and the same stirring speed as at the first stirring stage (the second stirring stage). Increased the mixture s temperature to 50 0 C and added 190ml distilled water, kept the stirring speed on par with that at the first stirring stage in 30 minutes (the third stirring stage). Adjusted the mixture s ph value to 4.5 by dropwise addition of 10% acetic acid solution at 40 0 C. Added 200ml distilled water and emulsified the mixture at stirring speed of 250rpm, temperature below 10 0 C in 60 minutes (the fourth stirring stage). Altered ph value of the mixture to 9.7 by 10% sodium hydroxide solution addition, then added 20ml 20% formaldehyde solution. Kept stirring at the speed of 250rpm, in 30 minutes, below 10 0 C to stablize the microcapsules. 22 hours later, centrifuged the mixture at the centrifugation speed of 4000rpm, at room temperature, in 15 minutes to collect microcapsules. After that the microcapsules were washed twice by 100ml distilled water below 10 0 C (centrifuged after each wash), vacuum filtered, and then washed once by solution of 25ml isopropanol and 25ml distilled water below 10 0 C [4]. The

obtained microcapsules were desiccated by freeze drying with the following parameters: temperature: -50 0 C, pressure: 0.007mbar, pre-freeze time: 4 hours and freeze drying time: 22-23 hours. Determination of microcapsules properties Size and shape of microcapsules Used an optical microscope, each sample of 50 microcapsules from 5% suspension of microcapsules in cold water; and utilized Scanning Electron Microscope (SEM). Vitamin A concentration Hydrolyzed fish liver oil samples (approximately equivalent to 1740IU Vitamin A) in fish liver oil material, microcapsules or standard Vitamin A palmitate by 1ml saturated potassium hydroxide solution, 2ml ethanol and 0.02 g BHT in an ultrasonic bath, in 30 minutes. Extracted Vitamin A once by 6ml n-hexane, washed n hexane extract by distilled water, evaporated n-hexane entirely to obtain solid deposit which was then dissloved in isopropanol. Diluted the resulted solution to the concentration range of 375IU/ml to 2350IU/ml. Ran these samples on a High Performance Liquid Chromatography system (HPLC) with the following parameters [2] : Supelco Discovery C8 Chromatographic column, 15cm x 4.6mm (5μm); Guard Column 2cm x 4.6mm (5μm); injected sample volume: 20μl; column temperature: 30 0 C; flow rate: 1.0ml/min; mobile phase: methanol:twice distilled water=95:5; detection wavelength: 325nm. Encapsulation Efficiency (EE) Encapsulation efficiency is percentage of Vitamin A in microcapsules in the total amount of Vitamin A in fish liver oil material used. Microcapsule Yield (MY) Calculated microcapsule yield by dividing the acquired microcapsules weight by the total weight of materials. Results and discussion Chromatograms of Vitamin A in HPLC analysis Ran HPLC with the Vitamin A treated samples to obtain chromatograms in image 1. The chromatograms gave a single, sharp and relatively symmetrical Vitamin A peak on a flat, little-noisy baseline with retention time of 2.6 min. 400 750 400 mau 200 m AU 500 250 mau 200 0 0 0 0 2 4 6 Minutes 0 2 4 6 Minutes 0 1 2 3 4 5 A B C Image 1: Chromatograms of the Vitamin A treated samples from fish liver oil microcapsules F D (A, the final formula, see below), standard Vitamin A palmitate (B) and fish liver oil material (C) Minutes The effects of core/wall ratio Prepared the formula F C11, altered core/wall ratio [the fish liver oil weight was 2.1g (F C12), 4.2g (F- C11) and 8.4g (F-C21)]. Properties of the resulted microcapsules were demonstrated in table 1.

Table 1: The effects of core/wall ratio on microcapsules properties F Core/wall ratio C (IU/g) Φ MC (μm) MY (%) EE (%) MC properties C12 1:2 326.33 51.27±11.4 82.09 65.32 Aggregation, hard to filter C11 1:1 523.27 50.42±12.0 80.25 62.95 Scattering, easy to filter C21 2:1 757.53 50.13±9.2 72.20 61.89 Aggregation, very hard to filter Annotation: C was Vitamin A concentration in microcapsules samples, Φ= diameter, MC=microcapsules. Table 1 indicated that when core/wall ratio varied from 1:2, 1:1, to 2:1, the microcapsules average size did not change (p>0.05), both encapsulation efficiency and microcapsule yield reached their maximums when the core/wall ratio was 1:2 (F- C12), and arrived at their minimums when the core/wall ratio was 2:1 (F-C21). These two fomulae produced aggregated and hard-to-filter microcapsules. On the other hand, microcapsules Table 2: The effects of emulsification stirring speed on microcapsules properties obtained by the formula core/wall ratio=1:1 (F- C11) were spherical, scattering and easy-to-filter. The effects of emulsification stirring speed Prepared the formula F C11, altered stirring speed at the first, second and third stages from 300rpm to 1000rpm. Properties of the resulted microcapsules were demonstrated in table 2. F v (v/ph) C (IU/g) Φ MC (μm) MY (%) EE (%) MC properties A 300 452.77 X X 59.42 Scattering, nonspherical, hard to filter B 400 496.43 X X 60.73 Scattering, nonspherical, hard to filter C 500 523.27 50.41±12.0 80.25 62.95 Scattering, spherical, easy to filter D 750 519.53 40.13±10.2 81.94 64.11 Scattering, spherical, easy to filter E 1000 556.79 26.46±9.1 79.33 63.27 Scattering, spherical, very easy to filter Annotation: X = undetermined As the emulsification stirring speed was 300rpm (F- A) and 400rpm (F-B), microcapsules were nonspherical, hard-to-filter. Be based on that and only encapsulation efficiency was investigated for these formulae. If the stirring speed increased from 500rpm to 1000rpm, then the microcapsules average size decreased correspondingly, EE and MY did not change significantly. In addition, the formulae with stirring speed of 500rpm (F-C) and 750rpm (F-D) created scattering microcapsules. EE of F-D was maximum. The effects of microencapsules stabilizing time Prepared the formula F D, altered the microencapsules stabilizing time from 8h, 15h to 22h. Properties of the resulted microcapsules were demonstrated in table 3. Table 3: The effects of the microencapsules stabilizing time on microcapsules properties F T (hours) C (IU/g) Φ MC (μm) MY (%) EE (%) MC properties T8 8 484.06 41.32±9.2 80.24 64.82 Aggregation, hard to filter T15 15 484.46 41.10±10.1 80.92 65.34 Scaterring, hard to filter D 22 476.15 40.82±9.7 81.94 64.11 Scaterring, easy to filter

When the microcapsules stabilizing time changed from 8h to 15h and 22h, the microcapsules average size, microcapsule yeild and encapsulation efficiency did not change (p>0.05). As the stabilizing time was more than 15h, microcapsules were scattering and easy to filter. As a result, the microcapsules stabilizing time 22h was selected to serve the study. The effects of coacervation ph value Prepared the formula F D (the microcapsules stabilizing time was 22h), altered coacervation ph value from 3.0 to 5.0. Properties of the resulted microcapsules were demonstrated in table 4. Table 4: The effects of coacervation ph value on microcapsules properties F ph C (IU/g) Φ MC (μm) MY (%) EE (%) MC properties H1 3.02 587.14 X X 53.91 Nonspherical, hard to filter H2 4.11 548.24 38.54±6.8 73.76 60.67 Scattering, spherical, easy to filter D 4.50 531.53 40,13±10.2 81.94 64.11 Scattering, spherical, easy to filter H4 5.06 525.40 40.02±8.6 77.40 61.05 Scattering, spherical, easy to filter When the coacervation ph value was 3.02, the microcapsules clustered, nonspherical, hence only encapsulation efficiency was studied. When the coacervation ph value varied from 4.11; 4.50 to 5.06, the microcapsules average size changed insignificantly. The ph value 4.50 brought about the maximum microcapsule yield (81.94%), the maximum encapsulation efficiency (64.11%), easyto-filter microcapsules. Be based on that and the coacervation ph value 4.50 (F-D) was choosed. The effects of concentration of formaldehyde solution Prepared the formula F D (the coacervation ph value was 4.50), altered concentration of formaldehyde solution from 10%, 20% to 30%. Properties of the resulted microcapsules were demonstrated in table 5. Table 5: The effects of concentration of formaldehyde solution on microcapsules properties F C formaldehyde (% w/v) C (IU/g) Φ MC (μm) MY (%) EE (%) MC properties F1 10 535.76 41.27±7.3 75.42 60.98 Scattering, easy to filter D 20 519.53 40.13±10.2 81.94 64.11 Scattering, easy to filter F3 30 520.11 42.45±8.9 83.03 65.13 Aggregation, hard to filter When the concentration of formaldehyde solution altered from 10%, 20% to 30%, the microcapsules average size changed insignificantly (p>0.05). The formula F-D (20% formadehyde) accounted for microcapsule yield and encapsulation effiency higher than F-F1 and lower than F-F3, but scattering microcapsules. The effects of ratio of gelatin/arabic gum (gel:gum) Prepared the formula F D (the concentration of formaldehyde solution was 20%), altered the gel: gum ratio: 3.75g:7.50g (1:2); 3.75g:3.75g (1:1); 7.50g:3.75g (2:1). Properties of the resulted microcapsules were demonstrated in table 6.

Hiep X. Nguyen et al. / Pharmaceutical Journal ISSN 0866-7225 No 437 Vol. 52 (2012) 6-10 Table 6: The effects of gel:gum ratio on microcapsules properties F gel:gum C (IU/g) Φ MC (μm) MY (%) EE (%) MC properties M 1:2 425.03 X X 58.89 Aggregation, nonspherical, very hard to filetr D 1:1 519,53 40.13 ± 10.2 81.94 64.11 Scattering, spherical, easy to filter P 2:1 472,13 41.91 ± 13.0 78.32 61.81 Aggregation, spherical, easy to filter When the gel:gum ratio was 1:2 (F-M), the product was nonspherical, cluster of polymers containing many fish liver oil droplets, encapsulation efficiency was lowest (58.89%). As the gel:gum ration was 2:1 (F-P), microcapsules were spherical with relatively equal size, but clustered with low MY and EE. When the gel:gum ratio was 1:1 (F-D), microcapsules were spherical, scattering, with relatively equal size and maximum encapsulation efficiency. The effects of weight of PVA Prepared the formula F D (the gel:gum ratio was 1:1), altered weight of PVA from 0.21g to 0.50g and 0.80g. Properties of the resulted microcapsules were demonstrated in table 7. Table 7: The effects of weight of PVA on microcapsules properties F PVA (g) C (IU/g) Φ MC (μm) MY (%) EE (%) MC properties P1 0,21 468.17 42.22±10.1 62.79 47.90 Scattering, easy to filter D 0,50 519.53 40.13±10.2 81.94 64.11 Scattering, easy to filter P3 0,80 450.12 40.89±9.4 83.30 64.05 Aggregation, easy to filter When the weight of PVA varied, the microcapsules average size changed insignificantly (p>0.05). As the weight of PVA increased from 0.21g (F-P1) to 0.80g (F-P3), microcapsule yield increased. Encapsulation efficiency reached its maximum (64.11%) when the weight of PVA was 0.50g (F-D) and its minimum (47.90%) when the weight of PVA was 0.21g (F-P1). Continuous augmentation of PVA weight to 0.80g (F-P3) did not lift the encapsulation efficiency, let alone made clustered, hard-to-filter microcapsules. F-D was selected as the final formula (F-D was similar to F-C11, only changed the emulsification stirring speed at the first, second and third stages to 750 rpm). The fundamental structure and size microcapsules were displayed in image A (optical microscope, 100X) B (SEM, magnification of 3000X) Image 2: Images of microcapsules (formula F-D) of 2.

Discussion Microencapsulation by complex coacervation method with gelatin-arabic gum is complicated, multi-stages, each stage affects the quality of microcapsules. In an alike study, Alavi et.al [1] demonstrated that as stirring speed increased, microcapsules average size decreased correspondingly. Besides, using 25% glutaraldehyde as the cross linking agent instead of formaldehyde brought the microcapsules more spherical shape, smooth surface with no obvious dents and narrower particle size distribution [1]. The project of Junyaprasert et. al [4] illustrated that the freeze drying method and the gel:gum ration=1:1 were appropriate to prepare Vitamin A palmitate microcapsules by complex coacervation method. Conclusion The study investigated the effects of some condition, formulation parameters on microencapsulation of fish liver oil by complex coacervation method, determined the suitable conditions and established rational formulation. References 1. Alavi T. H. et al. (2010), "Optimization of morphology and geometry of encapsulated Hypophthalmichthys molitrix oil", Iranian Journal of Fisheries Sciences, 9(2), p. 199-208. 2. Vietnam Ministry of Health. (2009), Appendix 10.10: "Vitamin A quatitative analysis, Method 5: High Performance Liquid Chromatography (HPLC) method after Vitamin A extraction", Viet Nam pharmacopoeia IV, Hanoi, p. PL 190-PL193. 3. James S. et al. (2007), "Microencapsulation Technology, Encyclopedia of Pharmaceutical Technology", Informa Healthcare, New York, 3(4), p. 2315 2332. 4. Junyaprasert, V. B. et al. (2001), "Effect of Process Variables on the Microencapsulation of Vitamin A Palmitate by Gelatin-Acacia Coacervation", Drug Development and Industrial Pharmacy, 27(6), p. 561 566.